Elizabeth David
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 25 | 2026 | 145 | 9.220 |
Why?
| | Pneumonectomy | 30 | 2025 | 169 | 7.350 |
Why?
| | Lung Neoplasms | 47 | 2026 | 2675 | 6.380 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 33 | 2026 | 1195 | 6.220 |
Why?
| | Thoracic Surgical Procedures | 15 | 2025 | 98 | 6.050 |
Why?
| | Surgeons | 11 | 2026 | 351 | 4.420 |
Why?
| | Physicians, Women | 5 | 2026 | 92 | 3.070 |
Why?
| | Neoplasm Staging | 25 | 2026 | 1488 | 2.620 |
Why?
| | Databases, Factual | 18 | 2025 | 1493 | 2.040 |
Why?
| | Esophageal Neoplasms | 12 | 2025 | 351 | 1.960 |
Why?
| | Esophagectomy | 12 | 2024 | 136 | 1.890 |
Why?
| | Societies, Medical | 10 | 2025 | 907 | 1.500 |
Why?
| | Chemotherapy, Adjuvant | 8 | 2022 | 429 | 1.120 |
Why?
| | Leadership | 2 | 2025 | 414 | 1.110 |
Why?
| | Career Choice | 5 | 2026 | 237 | 1.110 |
Why?
| | Registries | 5 | 2025 | 2400 | 1.020 |
Why?
| | Lymph Node Excision | 4 | 2025 | 174 | 0.940 |
Why?
| | Humans | 110 | 2026 | 146342 | 0.910 |
Why?
| | Guideline Adherence | 5 | 2026 | 594 | 0.900 |
Why?
| | Aged | 51 | 2026 | 26432 | 0.870 |
Why?
| | Treatment Outcome | 33 | 2025 | 11821 | 0.870 |
Why?
| | Mentors | 2 | 2025 | 217 | 0.850 |
Why?
| | Postoperative Complications | 19 | 2025 | 3034 | 0.850 |
Why?
| | Biomedical Research | 3 | 2025 | 729 | 0.840 |
Why?
| | Organizational Culture | 1 | 2026 | 159 | 0.830 |
Why?
| | Retrospective Studies | 47 | 2026 | 17438 | 0.820 |
Why?
| | Bone Neoplasms | 4 | 2023 | 272 | 0.820 |
Why?
| | Laparoscopy | 6 | 2024 | 487 | 0.820 |
Why?
| | Intraoperative Complications | 1 | 2025 | 157 | 0.800 |
Why?
| | Middle Aged | 49 | 2026 | 36619 | 0.800 |
Why?
| | Survival Rate | 14 | 2025 | 2092 | 0.790 |
Why?
| | Spouses | 1 | 2025 | 107 | 0.790 |
Why?
| | Periodicals as Topic | 2 | 2024 | 214 | 0.790 |
Why?
| | Workplace | 1 | 2026 | 268 | 0.790 |
Why?
| | Quality Improvement | 7 | 2025 | 1354 | 0.770 |
Why?
| | Specialties, Surgical | 2 | 2023 | 88 | 0.770 |
Why?
| | Adenocarcinoma | 3 | 2024 | 927 | 0.760 |
Why?
| | Propensity Score | 5 | 2025 | 376 | 0.750 |
Why?
| | Risk Assessment | 11 | 2025 | 3712 | 0.740 |
Why?
| | Lung Transplantation | 1 | 2025 | 326 | 0.690 |
Why?
| | Lymph Nodes | 3 | 2025 | 511 | 0.670 |
Why?
| | Male | 57 | 2026 | 73396 | 0.660 |
Why?
| | Female | 59 | 2026 | 79499 | 0.650 |
Why?
| | Social Class | 2 | 2020 | 260 | 0.650 |
Why?
| | Cisplatin | 1 | 2022 | 347 | 0.630 |
Why?
| | Clinical Decision-Making | 3 | 2020 | 365 | 0.630 |
Why?
| | Physician Executives | 1 | 2020 | 29 | 0.630 |
Why?
| | Time-to-Treatment | 5 | 2025 | 257 | 0.620 |
Why?
| | Family | 1 | 2025 | 690 | 0.620 |
Why?
| | Mesothelioma | 1 | 2020 | 50 | 0.590 |
Why?
| | Congresses as Topic | 1 | 2020 | 226 | 0.580 |
Why?
| | Ischemic Preconditioning | 3 | 2024 | 47 | 0.570 |
Why?
| | Chemoradiotherapy | 2 | 2017 | 238 | 0.570 |
Why?
| | Burnout, Professional | 1 | 2026 | 493 | 0.560 |
Why?
| | United States | 25 | 2026 | 16136 | 0.560 |
Why?
| | Internship and Residency | 4 | 2023 | 1281 | 0.550 |
Why?
| | Hernia, Hiatal | 3 | 2023 | 38 | 0.550 |
Why?
| | California | 5 | 2020 | 475 | 0.540 |
Why?
| | Survival Analysis | 6 | 2021 | 1378 | 0.530 |
Why?
| | Health Services Research | 1 | 2020 | 390 | 0.530 |
Why?
| | Carcinoid Tumor | 1 | 2017 | 21 | 0.520 |
Why?
| | Matched-Pair Analysis | 1 | 2017 | 38 | 0.500 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 543 | 0.490 |
Why?
| | Anastomotic Leak | 4 | 2024 | 46 | 0.490 |
Why?
| | Time Factors | 11 | 2024 | 7109 | 0.480 |
Why?
| | Esophageal Perforation | 2 | 2017 | 13 | 0.480 |
Why?
| | Sexual and Gender Minorities | 1 | 2020 | 269 | 0.470 |
Why?
| | Small Cell Lung Carcinoma | 3 | 2023 | 125 | 0.470 |
Why?
| | Neoplasm Invasiveness | 5 | 2022 | 504 | 0.460 |
Why?
| | Practice Management, Medical | 1 | 2015 | 28 | 0.460 |
Why?
| | Critical Pathways | 1 | 2017 | 104 | 0.450 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 332 | 0.440 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 51 | 0.430 |
Why?
| | Accreditation | 1 | 2015 | 100 | 0.430 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2024 | 196 | 0.420 |
Why?
| | Mediastinoscopy | 1 | 2014 | 5 | 0.410 |
Why?
| | Hypothermia | 2 | 2025 | 53 | 0.400 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2014 | 55 | 0.400 |
Why?
| | Practice Guidelines as Topic | 2 | 2026 | 1591 | 0.390 |
Why?
| | Radiosurgery | 3 | 2026 | 398 | 0.390 |
Why?
| | Thoracic Neoplasms | 3 | 2020 | 40 | 0.390 |
Why?
| | Pleural Neoplasms | 1 | 2013 | 31 | 0.380 |
Why?
| | Spinal Neoplasms | 2 | 2026 | 36 | 0.380 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1998 | 0.380 |
Why?
| | Prognosis | 9 | 2025 | 4351 | 0.370 |
Why?
| | Chest Tubes | 1 | 2013 | 32 | 0.370 |
Why?
| | Sexism | 2 | 2026 | 70 | 0.370 |
Why?
| | Pneumothorax | 1 | 2013 | 54 | 0.370 |
Why?
| | Drainage | 2 | 2013 | 187 | 0.360 |
Why?
| | Education, Medical | 1 | 2015 | 274 | 0.360 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1219 | 0.350 |
Why?
| | Qualitative Research | 3 | 2026 | 1734 | 0.350 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 34 | 0.340 |
Why?
| | Predictive Value of Tests | 5 | 2026 | 2113 | 0.340 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2011 | 48 | 0.340 |
Why?
| | Esophagus | 2 | 2021 | 260 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1408 | 0.330 |
Why?
| | Benchmarking | 2 | 2023 | 193 | 0.320 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 970 | 0.320 |
Why?
| | Salvage Therapy | 1 | 2011 | 166 | 0.320 |
Why?
| | Biopsy | 2 | 2014 | 1075 | 0.320 |
Why?
| | Lymphatic Metastasis | 4 | 2025 | 335 | 0.320 |
Why?
| | Anastomosis, Surgical | 3 | 2024 | 164 | 0.310 |
Why?
| | Device Removal | 1 | 2011 | 149 | 0.310 |
Why?
| | Risk Factors | 10 | 2024 | 10921 | 0.310 |
Why?
| | Healthcare Disparities | 3 | 2026 | 733 | 0.300 |
Why?
| | Follow-Up Studies | 11 | 2025 | 5439 | 0.300 |
Why?
| | Precision Medicine | 1 | 2014 | 462 | 0.300 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2219 | 0.290 |
Why?
| | Length of Stay | 6 | 2024 | 1358 | 0.280 |
Why?
| | Preoperative Care | 1 | 2011 | 396 | 0.280 |
Why?
| | Stents | 2 | 2017 | 554 | 0.280 |
Why?
| | Adult | 15 | 2026 | 41087 | 0.280 |
Why?
| | Interpersonal Relations | 2 | 2025 | 387 | 0.260 |
Why?
| | Triage | 2 | 2020 | 243 | 0.260 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1792 | 0.250 |
Why?
| | Peer Review, Research | 2 | 2017 | 36 | 0.240 |
Why?
| | Editorial Policies | 2 | 2017 | 46 | 0.240 |
Why?
| | Catheter Ablation | 2 | 2023 | 355 | 0.240 |
Why?
| | Thoracotomy | 2 | 2020 | 87 | 0.230 |
Why?
| | Palliative Care | 6 | 2026 | 1032 | 0.230 |
Why?
| | Aldosterone | 1 | 2026 | 42 | 0.230 |
Why?
| | Hyperaldosteronism | 1 | 2026 | 12 | 0.230 |
Why?
| | Patient Selection | 3 | 2020 | 728 | 0.230 |
Why?
| | Adrenal Glands | 1 | 2026 | 77 | 0.230 |
Why?
| | Veins | 1 | 2026 | 68 | 0.220 |
Why?
| | Smoking | 3 | 2024 | 1486 | 0.220 |
Why?
| | Vena Cava, Inferior | 1 | 2026 | 80 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 387 | 0.210 |
Why?
| | Coronavirus Infections | 2 | 2020 | 379 | 0.210 |
Why?
| | Patient Advocacy | 1 | 2025 | 73 | 0.210 |
Why?
| | Vulnerable Populations | 1 | 2025 | 178 | 0.200 |
Why?
| | Age Factors | 4 | 2026 | 3347 | 0.200 |
Why?
| | Esophageal Stenosis | 1 | 2024 | 60 | 0.190 |
Why?
| | Job Satisfaction | 1 | 2026 | 236 | 0.190 |
Why?
| | Esophagoscopy | 2 | 2017 | 223 | 0.190 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1331 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 235 | 0.190 |
Why?
| | Disease-Free Survival | 2 | 2016 | 778 | 0.190 |
Why?
| | Sex Distribution | 2 | 2020 | 382 | 0.180 |
Why?
| | Sex Factors | 3 | 2020 | 2107 | 0.180 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 190 | 0.180 |
Why?
| | Neoadjuvant Therapy | 5 | 2024 | 475 | 0.170 |
Why?
| | Aged, 80 and over | 8 | 2025 | 8391 | 0.170 |
Why?
| | North America | 1 | 2022 | 300 | 0.170 |
Why?
| | Carcinoma, Signet Ring Cell | 1 | 2021 | 17 | 0.170 |
Why?
| | Cohort Studies | 3 | 2017 | 6077 | 0.170 |
Why?
| | Patient Participation | 1 | 2025 | 457 | 0.160 |
Why?
| | Radiation Oncology | 1 | 2021 | 83 | 0.160 |
Why?
| | Social Determinants of Health | 1 | 2025 | 317 | 0.160 |
Why?
| | Vertebroplasty | 2 | 2019 | 6 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 516 | 0.160 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 29 | 0.160 |
Why?
| | Data Warehousing | 1 | 2020 | 5 | 0.160 |
Why?
| | Medical Oncology | 2 | 2021 | 345 | 0.160 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1327 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2023 | 210 | 0.160 |
Why?
| | Fellowships and Scholarships | 2 | 2023 | 355 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 288 | 0.160 |
Why?
| | Logistic Models | 2 | 2017 | 2126 | 0.150 |
Why?
| | Risk Adjustment | 1 | 2020 | 86 | 0.150 |
Why?
| | Biological Therapy | 1 | 2020 | 30 | 0.150 |
Why?
| | Paraneoplastic Syndromes | 1 | 2019 | 14 | 0.150 |
Why?
| | Thymoma | 1 | 2019 | 38 | 0.150 |
Why?
| | Cultural Diversity | 1 | 2020 | 83 | 0.150 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2020 | 88 | 0.150 |
Why?
| | Data Mining | 1 | 2020 | 113 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5899 | 0.150 |
Why?
| | Jejunostomy | 2 | 2010 | 13 | 0.150 |
Why?
| | Imidazoles | 1 | 2020 | 245 | 0.150 |
Why?
| | Incidence | 3 | 2023 | 2936 | 0.150 |
Why?
| | Photochemotherapy | 1 | 2019 | 39 | 0.140 |
Why?
| | Medically Uninsured | 1 | 2020 | 134 | 0.140 |
Why?
| | Stomach | 3 | 2024 | 106 | 0.140 |
Why?
| | Solitary Fibrous Tumor, Pleural | 1 | 2018 | 4 | 0.140 |
Why?
| | Pleura | 1 | 2018 | 28 | 0.140 |
Why?
| | Pain | 2 | 2023 | 790 | 0.140 |
Why?
| | Medicare | 1 | 2024 | 920 | 0.140 |
Why?
| | Herniorrhaphy | 3 | 2023 | 87 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1271 | 0.130 |
Why?
| | Thoracic Wall | 1 | 2017 | 22 | 0.130 |
Why?
| | Spine | 1 | 2019 | 184 | 0.130 |
Why?
| | Patient Discharge | 1 | 2024 | 997 | 0.130 |
Why?
| | Quebec | 1 | 2017 | 10 | 0.130 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 568 | 0.130 |
Why?
| | Lung | 3 | 2025 | 4122 | 0.120 |
Why?
| | Students, Medical | 1 | 2022 | 383 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2020 | 370 | 0.120 |
Why?
| | Bone Cements | 1 | 2017 | 39 | 0.120 |
Why?
| | Area Under Curve | 1 | 2017 | 335 | 0.120 |
Why?
| | Esophageal Diseases | 1 | 2017 | 29 | 0.120 |
Why?
| | Mediastinum | 1 | 2016 | 23 | 0.120 |
Why?
| | Data Accuracy | 1 | 2017 | 64 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 305 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 677 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2020 | 930 | 0.120 |
Why?
| | Sacrum | 1 | 2017 | 80 | 0.120 |
Why?
| | Medical Records | 1 | 2017 | 193 | 0.120 |
Why?
| | Hospital Costs | 1 | 2017 | 131 | 0.110 |
Why?
| | Prospective Studies | 5 | 2024 | 8123 | 0.110 |
Why?
| | Patient Readmission | 2 | 2023 | 778 | 0.110 |
Why?
| | ROC Curve | 1 | 2017 | 617 | 0.110 |
Why?
| | Writing | 1 | 2017 | 101 | 0.110 |
Why?
| | Bayes Theorem | 1 | 2017 | 426 | 0.110 |
Why?
| | Career Mobility | 1 | 2015 | 68 | 0.110 |
Why?
| | Cause of Death | 1 | 2017 | 456 | 0.110 |
Why?
| | Elective Surgical Procedures | 1 | 2017 | 216 | 0.110 |
Why?
| | Staff Development | 1 | 2015 | 64 | 0.110 |
Why?
| | Guidelines as Topic | 1 | 2017 | 267 | 0.110 |
Why?
| | Radiation Pneumonitis | 1 | 2015 | 31 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 260 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2020 | 611 | 0.100 |
Why?
| | Military Medicine | 1 | 2016 | 148 | 0.100 |
Why?
| | Goals | 1 | 2015 | 187 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2020 | 776 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2018 | 478 | 0.100 |
Why?
| | Mental Disorders | 1 | 2023 | 1148 | 0.100 |
Why?
| | Pandemics | 4 | 2025 | 1707 | 0.100 |
Why?
| | Pleural Effusion, Malignant | 1 | 2013 | 12 | 0.100 |
Why?
| | Chylothorax | 1 | 2013 | 20 | 0.090 |
Why?
| | Empyema | 1 | 2013 | 8 | 0.090 |
Why?
| | Hemothorax | 1 | 2013 | 19 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2015 | 471 | 0.090 |
Why?
| | Clinical Protocols | 2 | 2024 | 282 | 0.090 |
Why?
| | Paraganglioma, Extra-Adrenal | 1 | 2012 | 10 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 874 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 426 | 0.090 |
Why?
| | Thoracic Cavity | 1 | 2011 | 2 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6073 | 0.090 |
Why?
| | Morbidity | 2 | 2023 | 319 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 930 | 0.090 |
Why?
| | Stomach Rupture | 1 | 2011 | 3 | 0.090 |
Why?
| | Heart Neoplasms | 1 | 2012 | 56 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1408 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2017 | 436 | 0.080 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2011 | 29 | 0.080 |
Why?
| | Heart Atria | 1 | 2012 | 139 | 0.080 |
Why?
| | Equipment Design | 1 | 2013 | 520 | 0.080 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1160 | 0.080 |
Why?
| | Prosthesis Failure | 1 | 2011 | 126 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 447 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2015 | 702 | 0.080 |
Why?
| | Supine Position | 1 | 2010 | 39 | 0.080 |
Why?
| | Patient Positioning | 1 | 2010 | 73 | 0.080 |
Why?
| | Patient Care Team | 1 | 2015 | 701 | 0.080 |
Why?
| | Gastrectomy | 1 | 2011 | 164 | 0.070 |
Why?
| | Genomics | 1 | 2015 | 853 | 0.070 |
Why?
| | Suture Techniques | 1 | 2010 | 138 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2014 | 1135 | 0.070 |
Why?
| | Gastrostomy | 1 | 2010 | 124 | 0.070 |
Why?
| | Aorta | 1 | 2012 | 440 | 0.070 |
Why?
| | Sarcoma | 1 | 2011 | 209 | 0.070 |
Why?
| | Military Personnel | 1 | 2016 | 726 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 349 | 0.070 |
Why?
| | Immunotherapy | 2 | 2023 | 671 | 0.060 |
Why?
| | Radiography, Interventional | 1 | 2007 | 128 | 0.060 |
Why?
| | Phlebography | 1 | 2026 | 38 | 0.060 |
Why?
| | SEER Program | 1 | 2026 | 233 | 0.060 |
Why?
| | Quality of Life | 3 | 2023 | 3200 | 0.050 |
Why?
| | Lung Diseases | 1 | 2011 | 787 | 0.050 |
Why?
| | Forced Expiratory Volume | 1 | 2025 | 451 | 0.050 |
Why?
| | Emergencies | 1 | 2025 | 177 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2954 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2024 | 240 | 0.050 |
Why?
| | Carbon Monoxide | 1 | 2023 | 82 | 0.050 |
Why?
| | Hospitalization | 2 | 2023 | 2475 | 0.050 |
Why?
| | Reoperation | 2 | 2017 | 645 | 0.040 |
Why?
| | Forecasting | 1 | 2023 | 388 | 0.040 |
Why?
| | Surgical Mesh | 1 | 2021 | 54 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2022 | 129 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 467 | 0.040 |
Why?
| | Cementoplasty | 1 | 2020 | 2 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2025 | 553 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 222 | 0.040 |
Why?
| | Kyphoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Brachytherapy | 1 | 2020 | 132 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2219 | 0.040 |
Why?
| | Pain Measurement | 1 | 2020 | 573 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 399 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 287 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2026 | 3416 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 404 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 212 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 163 | 0.030 |
Why?
| | Europe | 1 | 2017 | 421 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3017 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 352 | 0.030 |
Why?
| | Canada | 1 | 2017 | 432 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3647 | 0.030 |
Why?
| | Anniversaries and Special Events | 1 | 2016 | 16 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 14330 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2017 | 368 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 925 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 224 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 330 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4340 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 360 | 0.030 |
Why?
| | Child, Preschool | 2 | 2019 | 11913 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 598 | 0.020 |
Why?
| | Clinical Competence | 1 | 2021 | 1272 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 1221 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 2011 | 20 | 0.020 |
Why?
| | Neoplasm, Residual | 1 | 2012 | 143 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2012 | 306 | 0.020 |
Why?
| | Laparotomy | 1 | 2011 | 111 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 325 | 0.020 |
Why?
| | Lymphoma, B-Cell | 1 | 2011 | 150 | 0.020 |
Why?
| | Adolescent | 2 | 2019 | 22557 | 0.020 |
Why?
| | Child | 2 | 2019 | 22693 | 0.020 |
Why?
| | Wound Healing | 1 | 2011 | 354 | 0.020 |
Why?
| | Gastric Outlet Obstruction | 1 | 2007 | 12 | 0.020 |
Why?
| | Intestinal Obstruction | 1 | 2007 | 54 | 0.020 |
Why?
| | Fluoroscopy | 1 | 2007 | 179 | 0.020 |
Why?
| | Digestive System Surgical Procedures | 1 | 2007 | 115 | 0.020 |
Why?
| | Ultrasonography, Interventional | 1 | 2007 | 163 | 0.010 |
Why?
| | Stomach Neoplasms | 1 | 2007 | 128 | 0.010 |
Why?
| | Infant | 1 | 2019 | 10114 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2921 | 0.010 |
Why?
| | Mice | 1 | 2015 | 18297 | 0.010 |
Why?
| | Animals | 1 | 2015 | 38107 | 0.010 |
Why?
| | Carcinoma, Bronchogenic | 1 | 1970 | 20 | 0.010 |
Why?
| | Bronchial Neoplasms | 1 | 1970 | 15 | 0.010 |
Why?
| | Hemoptysis | 1 | 1970 | 34 | 0.000 |
Why?
| | Cough | 1 | 1970 | 123 | 0.000 |
Why?
| | Bronchoscopy | 1 | 1970 | 227 | 0.000 |
Why?
| | Bronchi | 1 | 1970 | 263 | 0.000 |
Why?
| | Sputum | 1 | 1970 | 302 | 0.000 |
Why?
|
|
David's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|